Transition of Enterococcus faecium from commensal organism to nosocomial pathogen

Future Microbiology

Volumn 4, Issue 9, 2009, Pages 1125-1135

  Willems, Rob J L ^a   Van Schaik, Willem ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CC17; Enterococcus faecium; Nosocomial pathogen; Population biology; Surface protein

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; CIPROFLOXACIN; DAPTOMYCIN; HYALURONIDASE; LINEZOLID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; COMMENSAL; ENDEMIC DISEASE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EPIDEMIC; HOSPITAL INFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECIUM; GENOME, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MEMBRANE PROTEINS; VIRULENCE;

ENTEROCOCCUS FAECIUM; MAMMALIA; POSIBACTERIA;

EID: 73649086225     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.82     Document Type: Review

References (94)

1. Devriese L, Baele M, Butaye P: The genus Enterococcus. In: The Prokaryotes (3rd Edition). A Handbook on the Biology of Bacteria: Bacteria: Firmicutes, Cyanobacteria. Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E (Eds). Springer, NY, USA, 163-174 (2006).
2. Naser S, Thompson FL, Hoste B et al.: Phylogeny and identification of enterococci by atpA gene sequence analysis. J. Clin. Micro Biol. 43, 2224-2230 (2005).
3. Huycke MM: Physiology of enterococci. In: The Enterococci: Pathogenesis, Molecular Biology and Antibiotic Resistance. Gilmore MS, Clewell DB, Courvalin P, Dunny GM, Murray BE, Rice LB (Eds). American Society for Microbiology, Washington, DC, USA, 133-175 (2002).
4. Leblanc D: Enterococcus. In: The Prokaryotes (3rd Edition). A Handbook on the Biology of Bacteria: Bacteria: Firmicutes, Cyanobacteria. Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E (Eds). Springer, NY, USA, 175-204 (2006).
5. Noble CJ: Carriage of group D streptococci in the human bowel. J. Clin. Pathol. 31, 1182-1186 (1978).
6. Tannock GW, Munro K, Harmsen HJ et al.: Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Micro Biol. 66, 2578-2588 (2000).
7. Matsuda K, Tsuji H, Asahara T et al.: Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl. Environ. Micro Biol. 75, 1961-1969 (2009).
8. Thadepalli H, Lou MA, Bach VT, Matsui TK, Mandal AK: Microflora of the human small intestine. Am. J. Surg. 138, 845-850 (1979).
9. Hayashi H, Takahashi R, Nishi T, Sakamoto M, Benno Y: Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J. Med. Micro Biol. 54, 1093-1101 (2005).
10. Scharek L, Guth J, Reiter K et al.: Influence of a probiotic Enterococcus faecium strain on development of the immune system of sows and piglets. Vet. Immunol. Immunopathol. 105, 151-161 (2005).
11. Strompfova V, Marcinakova M, Simonova M et al.: Enterococcus faecium EK13 - an enterocin A-producing strain with probiotic character and its effect in piglets. Anaerobe 12, 242-248 (2006).
12. Pollmann M, Nordhoff M, Pospischil A, Tedin K, Wieler LH: Effects of a probiotic strain of Enterococcus faecium on the rate of natural Chlamydia infection in swine. Infect. Immun. 73, 4346-4353 (2005).
13. Bates J, Jordens JZ, Griffiths DT: Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J. Antimicrob. Chemo Ther. 34, 507-514 (1994).
14. Devriese LA, Ieven M, Goossens H et al.: Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob. Agents Chemo Ther. 40, 2285-2287 (1996).
15. Aarestrup FM, Butaye P, Witte W: Nonhuman reservoirs of enterococci. In: The Enterococci: Pathogenesis, Molecular Biology and Antibiotic Resistance. Gilmore MS, Clewell DB, Courvalin P, Dunny GM, Murray BE, Rice LB (Eds). American Society for Microbiology, Washington, DC, USA, 55-99 (2002).
16. Coque TM, Willems R, Canton R, Del Campo R, Baquero F: High occurrence of esp among ampicillin-resistant and vancomycinsusceptible Enterococcus faecium clones from hospitalized patients. J. Antimicrob. Chemo Ther. 50, 1035-1038 (2002).
17. Leavis HL, Willems RJ, Top J et al.: Epidemic and nonepidemic multidrug-resistant Enterococcus faecium. Emerg. Infect. Dis. 9, 1108-1115 (2003).
18. Willems RJ, Top J, van Santen M et al.: Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg. Infect. Dis. 11, 821-828 (2005).
19. Grayson ML, Eliopoulos GM, Wennersten CB et al.: Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob. Agents Chemo Ther. 35, 2180-2184 (1991).
20. Ammerlaan HS, Troelstra A, Kruitwagen CL, Kluytmans JA, Bonten MJ: Quantifying changes in incidences of nosocomial bacteraemia caused by antibiotic-susceptible and antibiotic-resistant pathogens. J. Antimicrob. Chemo Ther. 63, 1064-1070 (2009).
21. Top J, Willems R, Blok H et al.: Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin. Microbiol. Infect. 13, 316-319 (2007).
22. Iwen PC, Kelly DM, Linder J et al.: Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob. Agents Chemo Ther. 41, 494-495 (1997).
23. Murdoch DR, Mirrett S, Harrell LJ, Monahan JS, Reller LB: Sequential emergence of antibiotic resistance in enterococcal bloodstream isolates over 25 years. Antimicrob. Agents Chemo Ther. 46, 3676-3678 (2002).
24. Treitman AN, Yarnold PR, Warren J, Noskin GA: Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J. Clin. Micro Biol. 43, 462-463 (2005).
25. Hidron AI, Edwards JR, Patel J et al.: NHSN annual update: antimicrobial-resistant pathogens associated with healthcareassociated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29, 996-1011 (2008).
26. Aksoy DY, Unal S: New antimicrobial agents for the treatment of Gram-positive bacterial infections. Clin. Microbiol. Infect. 14, 411-420 (2008).
27. Montero CI, Stock F, Murray PR: Mechanisms of resistance to daptomycin in Enterococcus faecium. Antimicrob. Agents Chemo Ther. 52, 1167-1170 (2008).
28. Scheetz MH, Knechtel SA, Malczynski M, Postelnick MJ, Qi C: Increasing incidence of linezolid-intermediate or-resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption. Antimicrob. Agents Chemo Ther. 52, 2256-2259 (2008).
29. Goossens H: Spread of vancomycin-resistant enterococci: differences between the USA and europe. Infect. Control Hosp. Epidemiol. 19, 546-551 (1998).
30. Hayden MK: Insights into the epidemiology and control of infection with vancomycinresistant enterococci. Clin. Infect. Dis. 31, 1058-1065 (2000).
31. Bonten MJM, Hayden MK, Nathan C et al.: Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348, 1615-1619 (1996).
32. Suppola JP, Kolho E, Salmenlinna S et al.: vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality. J. Clin. Micro Biol. 37, 3934-3939 (1999).
33. Novais C, Sousa JC, Coque TM, Peixe LV: Molecular characterization of glycopeptideresistant Enterococcus faecium isolates from Portuguese hospitals. Antimicrob. Agents Chemo Ther. 49, 3073-3079 (2005).
34. Kawalec M, Gniadkowski M, Hryniewicz W; Active Bacterial Core Surveillance, Canadian Womens HIV Study Group: Outbreak of vancomycin-resistant enterococci in a hospital in Gdansk, Poland, due to horizontal transfer of different tnl546-like transposon variants and clonal spread of several strains. J. Clin. Micro Biol. 38, 3317-3322 (2000).
35. Kawalec M, Gniadkowski M, Zaleska M et al.: Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype Van B in a hospital in Warsaw, Poland: probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain. J. Clin. Micro Biol. 39, 1781-1787 (2001).
36. Werner G, Klare I, Spencker FB, Witte W: Intra-hospital dissemination of quinupristin /dalfopristin-and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital. J. Antimicrob. Chemo Ther. 52, 113-115 (2003).
37. Werner G, Klare I, Fleige C, Witte W: Increasing rates of vancomycin resistance among Enterococcus faecium isolated from German hospitals between 2004 and 2006 are due to wide clonal dissemination of vancomycin-resistant enterococci and horizontal spread of vanA clusters. Int. J. Med. Micro Biol. 298, 515-527 (2008).
38. Talebi M, Pourshafie MR, Katouli M, Mollby R: Molecular structure and transferability of Tnl546-like elements in Enterococcus faecium isolated from clinical, sewage and surface water samples in Iran. Appl. Environ. Micro Biol. 74, 1350-1356 (2008).
39. Zheng B, Tomita H, Xiao YH et al.: Molecular characterization of vancomycinresistant Enterococcus faecium isolates from mainland China. J. Clin. Micro Biol. 45, 2813-2818 (2007).
40. Yoo SJ, Sung H, Cho YU et al.: Role of horizontal transfer of the transposon Tnl546 in the nosocomial spread of vanA vancomycin-resistant enterococci at a tertiary care hospital in Korea. Infect. Control Hosp. Epidemiol. 27, 1081-1087 (2006).
41. Nichol KA, Sill M, Laing NM et al.: Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America. Int. J. Antimicrob. Agents 27, 392-396 (2006).
42. de Regt MJ, van der Wagen LE, Top J et al.: High acquisition and environmental contamination rates of CC17 ampicillinresistant Enterococcus faecium in a Dutch hospital. J. Antimicrob. Chemo Ther. 62, 1401-1406 (2008).
43. Harthug S, Jureen R, Mohn SC et al.: The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals. J. Hosp. Infect. 50, 145-154 (2002).
44. Lester CH, Sandvang D, Olsen SS et al.: Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals. J. Antimicrob. Chemo Ther. 62, 1203-1206 (2008).
45. Belhaj M, Boutiba-Ben Boubaker I, Ben Redjeb S, Bouchami O: Molecular characterisation of high-level ampicillinresistant Enterococcus faecium isolates from hospitalised patients in Tunis. Int. J. Antimicrob. Agents 32, 284-286 (2008).
46. Oteo J, Cuevas O, Navarro C, Aracil B, Campos J: Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EARSS experience 2001-2006, Spain) : increasing ampicillin resistance in Enterococcus faecium. J. Antimicrob. Chemo Ther. 59, 1044-1045 (2007).
47. Torell E, Kuhn I, Olsson-Liljequist B et al.: Clonality among ampicillin-resistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance. Clin. Microbiol. Infect. 9, 1011-1019 (2003).
48. Simonsen GS, Smabrekke L, Monnet DL et al.: Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J. Antimicrob. Chemo Ther. 51, 323-331 (2003).
49. Coque TM, Willems RJ, Fortun J et al.: Population structure of Enterococcus faecium causing bacteremia in a Spanish university hospital: setting the scene for a future increase in vancomycin resistance? Antimicrob. Agents Chemo Ther. 49, 2693-2700 (2005).
50. Paulsen IT, Banerjei L, Myers GS et al.: Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299, 2071-2074 (2003).
51. Leavis HL, Willems RJ, van Wamel WJ et al.: Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog. 3, 75-96 (2007).
52. Willems RJL, Top J, Van Den Braak N et al.: Host specificity of vancomycin-resistant Enterococcus faecium. J. Infect. Dis. 182, 816-823 (2000).
53. Vancanneyt M, Lombardi A, Andrighetto C et al.: Intraspecies genomic groups in Enterococcus faecium and their correlation with origin and pathogenicity. Appl. Environ. Micro Biol. 68, 1381-1391 (2002).
54. Heikens E, Bonten MJ, Willems RJ: Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J. Bacteriol. 189, 8233-8240 (2007).
55. Homan WL, Tribe D, Poznanski S et al.: Multilocus sequence typing scheme for Enterococcus faecium. J. Clin. Micro Biol. 40, 1963-1971 (2002).
56. Bonora MG, Olioso D, Lo Cascio G, Fontana R: Phylogenetic analysis of vancomycin-resistant Enterococcus faecium genotypes associated with outbreaks or sporadic infections in Italy. Microb. Drug Resist. 13, 171-177 (2007).
57. Khan MA, van der Wal M, Farrell DJ et al.: Analysis of Van A vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tnl546 lineage types. J. Antimicrob. Chemo Ther. 62, 279-283 (2008).
58. Nallapareddy SR, Singh KV, Okhuysen PC, Murray BE: A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect. Immun. 76, 4110-4119 (2008).
59. Lopez M, Hormazabal JC, Maldonado A et al.: Clonal dissemination of Enterococcus faecalis ST201 and Enterococcus faecium CC17-ST64 containing Tn5382-vanB2 among 16 hospitals in Chile. Clvin. Microbiol. Infect. 15, 586-588 (2009).
60. Zhu X, Zheng B, Wang S et al.: Molecular characterisation of outbreak-related strains of vancomycin-resistant Enterococcus faecium from an intensive care unit in Beijing, China. J. Hosp. Infect. 72, 147-154 (2009).
61. Mato R, Almeida F, Pires R et al.: Assessment of high-level gentamicin and glycopeptide-resistant Enterococcus faecalis and E. faecium clonal structure in a Portuguese hospital over a 3-year period. Eur. J. Clin. Microbiol. Infect. Dis. 28, 855-859 (2009).
62. Valdezate S, Labayru C, Navarro A et al.: Large clonal outbreak of multidrug-resistant CC17 ST17 Enterococcus faecium containing Tn5382 in a Spanish hospital. J. Antimicrob. Chemo Ther. 63, 17-20 (2009).
63. Klare I, Konstabel C, Mueller-Bertling S et al.: Spread of ampicillin/vancomycinresistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 24, 815-825 (2005).
64. Francisco AP, Bugalho M, Ramirez M, Carrico JA: Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach. BMC Bioinformatics 10, 152 (2009).
65. Turner KM, Hanage WP, Fraser C, Connor TR, Spratt BG: Assessing the reliability of eBURST using simulated populations with known ancestry. BMC Micro Biol. 7, 30 (2007).
66. Didelot X, Falush D: Inference of bacterial microevolution using multilocus sequence data. Genetics 175, 1251-1266 (2007).
67. Damborg P, Sorensen AH, Guardabassi L: Monitoring of antimicrobial resistance in healthy dogs: first report of canine ampicillin-resistant Enterococcus faecium clonal complex 17. Vet. Micro Biol. 132, 190-196 (2008).
68. Damborg P, Top J, Hendrickx AP et al.: Dogs are a reservoir of ampicillin-resistant Enterococcus faecium lineages associated with human infections. Appl. Environ. Micro Biol. 75, 2360-2365 (2009).
69. Lee WG, Lee SM, Kim YS: Molecular characterization of Enterococcus faecium isolated from hospitalized patients in Korea. Lett. Appl. Micro Biol. 43, 274-279 (2006).
70. Camargo IL, Gilmore MS, Darini AL: Multilocus sequence typing and analysis of putative virulence factors in vancomycinresistant and vancomycin-sensitive Enterococcus faecium isolates from Brazil. Clin. Microbiol. Infect. 12, 1123-1130 (2006).
71. Ergani-Ozcan A, Naas T, Baysan BO et al.: Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital. J. Antimicrob. Chemo Ther. 61, 1033-1039 (2008).
72. Freitas AR, Novais C, Ruiz-Garbajosa P, Coque TM, Peixe L: Dispersion of multidrug resistant Enterococcus faecium belonging to major clonal complexes in different Portuguese settings. Appl. Environ. Micro Biol. 75, 4904-4908 (2009).
73. Feil EJ: Small change: keeping pace with microevolution. Nat. Rev. Micro Biol. 2, 483-495 (2004).
74. Willems RJL, Homan W, Top J et al.: Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357, 853-855 (2001).
75. Woodford N, Soltani M, Hardy KJ: Frequency of esp in Enterococcus faecium isolates. Lancet 358, 584 (2001).
76. Baldassarri L, Bertuccini L, Ammendolia MG, Gherardi G, Creti R: Variant esp gene in vancomycin-sensitive Enterococcus faecium. Lancet 357, 1802 (2001).
77. Worth LJ, Slavin MA, Vankerckhoven V et al.: Virulence determinants in vancomycinresistant Enterococcus faecium van B.: clonal distribution, prevalence and significance of esp and hyl in Australian patients with haematological disorders. J. Hosp. Infect. 68, 137-144 (2008).
78. Song JH, Ko KS, Oh WS et al.: High frequency of vancomycin-resistant Enterococcus faecium isolates with Van B phenotype and van A genotype in Korean hospitals. Diagn. Microbiol. Infect. Dis. 56, 401-406 (2006).
79. Leavis H, Top J, Shankar N et al.: A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J. Bacteriol. 186, 672-682 (2004).
80. Leendertse M, Heikens E, Wijnands LM et al.: Enterococcal surface protein transiently aggravates Enterococcus faecium induced urinary tract infection in mice. J. Infect. Dis. 200 (7), 1162-1165 (2009).
81. Leavis HL, Willems RJ, Top J, Bonten MJ: High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. J. Clin. Micro Biol. 44, 1059-1064 (2006).
82. Nallapareddy SR, Sillanpaa J, Ganesh VK, Hook M, Murray BE: Inhibition of Enterococcus faecium adherence to collagen by antibodies against high-affinity binding subdomains of Acm. Infect. Immun. 75, 3192-3196 (2007).
83. Nallapareddy SR, Singh KV, Murray BE: Contribution of the collagen adhesin Acm to pathogenesis of Enterococcus faecium in experimental endocarditis. Infect. Immun. 76, 4120-4128 (2008).
84. Hendrickx AP, van Wamel WJ, Posthuma G, Bonten MJ, Willems RJ: Five genes encoding surface-exposed LPXTG proteins are enriched in hospital-adapted Enterococcus faecium clonal complex 17 isolates. J. Bacteriol. 189, 8321-8332 (2007).
85. Hendrickx APA, van Luit-Asbroek M, Schapendonk CME et al.: Sgr A, a nidogenbinding LPXTG surface adhesin implicated in biofilm formation, and EcbA, a collagen binding MSCRAMM of hospital acquired Enterococcus faecium. Infect. Immun. (2009) (Epub ahead of print).
86. Sillanpaa J, Nallapareddy SR, Prakash VP et al.: Identification and phenotypic characterization of a second collagen adhesin, Scm, and genome-based identification and analysis of 13 other predicted MSCRAMMs, including four distinct pilus loci, in Enterococcus faecium. Microbiology 154, 3199-3211 (2008).
87. Sillanpaa J, Prakash VP, Nallapareddy SR, Murray BE: Distribution of genes encoding MSCRAMMs and pili in clinical and natural populations of Enterococcus faecium. J. Clin. Micro Biol. 47, 896-901 (2009).
88. Efm, predominates in Enterococcus faecium of clinical origin. J. Infect. Dis. 187, 508-512 (2003).
89. Hendrickx AP, Bonten MJ, van Luit-Asbroek M et al.: Expression of two distinct types of pili by a hospital-acquired Enterococcus faecium isolate. Microbiology 154, 3212-3223 (2008).
90. Maisey HC, Quach D, Hensler ME et al.: Group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J. 22, 1715-1724 (2008).
91. Abbot EL, Smith WD, Sion GP et al.: Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin. Cell. Micro Biol. 9, 1822-1833 (2007).
92. Mandlik A, Swierczynski A, Das A, Ton-That H: Corynebacterium diphtheriae employs specific minor pilins to target human pharyngeal epithelial cells. Mol. Micro Biol. 64, 111-124 (2007).
93. Heikens E, van Schaik W, Leavis HL, Bonten MJ, Willems RJ: Identification of a novel genomic island specific to hospitalacquired clonal complex 17 Enterococcus faecium isolates. Appl. Environ. Micro Biol. 74, 7094-7097 (2008).
94. Baquero F: From pieces to patterns: evolutionary engineering in bacterial pathogens. Nat. Rev. Micro Biol. 2, 510-518 (2004).